Form D · Other Health Care
Thermaquil, Inc.
Philadelphia, PA · CIK 0001771071
Offering snapshot reported Mar 21, 2019 · SEC filing
- Reported sold
- $405K Indefinite offering
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 22, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2019 | Initial | $405,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-335420
Source: Form D, filed Mar 21, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tai Changfeng | Director |
| Stephen R. Popielarski | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3401 Market Street, Suite 200
Philadelphia, PA, 19104
Philadelphia, PA, 19104